Navigation Links
ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM
Date:3/3/2008

SACRAMENTO, Calif., March 3 /PRNewswire/ -- ROBODOC, a Curexo Technology Company, and IBM announced today that they have entered into a major patent Cross licensing agreement. The terms of the agreement were not disclosed by either party.

In addition to its current surgical robotics patents, this agreement gives ROBODOC, access to more than 40,000 patents in IBM'S Global Portfolio and particularly, IBM's surgical robotics patents.

Dan Cerutti, IBM's general manager of intellectual property, said, "IBM enjoys a reputation of innovation and invention for technologies related to computer-assisted medicine and surgery. We are pleased to share our innovations in these areas through patent cross licenses, especially with forward-thinking companies such as ROBODOC."

"This agreement provides us with a significant improvement in our freedom of action in the Surgical Robotics and Information Management field. We intend to continue building our own intellectual property portfolio on an on-going basis," commented Dr. Ramesh Trivedi, President and CEO of ROBODOC.

IBM has earned the most U.S. patents for 15 consecutive years. For more information on IBM, please visit http://www.ibm.com.

ROBODOC, a Curexo Technology Company is the United States-based subsidiary of Korea-based Curexo Inc. (KOSDAQ: 060280.KQ). Its main research facility is in the U.S. and it reaches markets throughout the world.

About ROBODOC

ROBODOC, develops, manufactures, and markets a fully automated surgical robotic system for use in orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robotic assistant for use in hip and knee replacement as well as other orthopaedic procedures. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures assisting surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.

ROBODOC(R) and ORTHODOC(R) are registered trade marks of Curexo Technology Corporation.
1433 N. Market Blvd., Suite 1, Sacramento, CA 95834

http://www.robodoc.com

Contact: Dr. R.C. Trivedi

President & CEO

ROBODOC(R)

A Curexo Technology Company

916 285 9943 x 527

or

Ms. Sheila Shah

Marketing Communications

ROBODOC(R)

A Curexo Technology Company

916 285 9943 X 510

press@robodoc.com


'/>"/>
SOURCE ROBODOC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... ... July 18, 2017 , ... G-CON today announced that ... Office for its Patent Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile ... further expand the protection of G-CON’s R&D investments and validate the G-CON platform ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope Foundation ... the first phase of the Allotrope Framework for commercial use. , The Bio-IT ... to “not only elevate the critical role of information technology in modern biomedical ...
(Date:7/17/2017)... ... , ... Whitehouse Laboratories is excited to announce that it ... of ISO 80369 standard test procedures. The ISO 80369 series of eight test ... With this recent expansion, Whitehouse Labs becomes one of the only facilities in ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... announced safety software company AB Cube has joined its eHealth App ... advance technology innovation across life sciences and healthcare. Under the partnership, AB ...
Breaking Biology Technology:
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):